Advertisement
Persons > All
Total search results: 2420 | Ordered by Position (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Berthuin, Jeremy (France (govt) 201701 Head of Healthcare Sector at Bpifrance) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
Bonnell, Bruno (French (govt) 202310 Secretary General for Investments) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
Flon, Aude (Sud de France 201111 Project Manager Multi-industrial Sector) | Administrative Officer (personnel) | Sud de France Développement | Occitanie (Occitania) (region) |
Geoghegan-Quinn, Máire (EU (govt) 201103 Commissioner for Research, Innovation and Science) | Administrative Officer (personnel) | EU (govt) | Brussels (region) |
Pannier-Runacher, Agnès (France (govt) 202107 Minister Delegate for Industry) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
Pénicaud, Muriel (France (govt) 201601 Head of Business France) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
Riester, Franck (France (govt) 202107 Minister Delegate for Foreign Trade and Economic Attractiveness) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
Vassiliou, Androula (EU 200802– Health Commissioner) | Administrative Officer (personnel) | EU (govt) | Brussels (region) |
El Bougrini, Jamila (Bryan Garnier 201710– Healhcare Equity Research Analyst in Paris) | Analyst (Financial / Industry) | Bryan, Garnier (Group) | Île-de-France (region) |
Levi, Marion (Bryan Garnier 201710– Healhcare Equity Research Analyst in Paris) | Analyst (Financial / Industry) | Bryan, Garnier (Group) | Île-de-France (region) |
Smolentseva, Olga (Bryan Garnier 202110 Equity Research Analyst Biotechnology) | Analyst (Financial / Industry) | Bryan, Garnier (Group) | Île-de-France (region) |
Waicenberg, Jeremie (Mérieux 202104 Senior Business Analyst at Mérieux Equity Partners) | Analyst (Financial / Industry) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
Zoller, Jessica (France (govt) 202004 Life Science Analyst at Bpifrance) | Analyst (Financial / Industry) | France (govt) | Île-de-France (region) |
Fernandez, Facundo (Georgia Tech 201008 Assoc Professor School of Chemistry and Biochemistry) | Assistant Professor / Associate Professor | Georgia Institute of Technology (Georgia Tech) | Georgia (state) |
Rottmann, Martin (Univ Versailles 201012 Associate Professor + Hospital Raymond Ponicaré, Garches) | Assistant Professor / Associate Professor | University of Versailles-Saint-Quentin-en-Yvelines (UVSQ) | Île-de-France (region) |
Aberg, Louise (McDermott Will & Emery 201701 Associate in Life Sciences Group in Paris) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Île-de-France (region) |
Bloch, Maxence (Goodwin Procter 202104 Chair of Paris Office) | Attorney / Lawyer | Goodwin Procter (Goowin Law) (Group) | Île-de-France (region) |
Dupont-Sentilles, Thomas (Goodwin Procter 202104 Partner at Paris Office) | Attorney / Lawyer | Goodwin Procter (Goowin Law) (Group) | Île-de-France (region) |
Garçon, Benjamin (Goodwin Procter 202104 Partner at Paris Office) | Attorney / Lawyer | Goodwin Procter (Goowin Law) (Group) | Île-de-France (region) |
Monjou, Raphaëlle (McDermott Will & Emery 201701 Associate in Life Sciences Group in Paris) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Île-de-France (region) |
Paronneau, Anthony (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Île-de-France (region) |
Regniault, Alexandre (Simmons & Simmons 201509 Partner in Paris Office + France Biotech 201508 Board Member) | Attorney / Lawyer | Simmons & Simmons (Group) | Île-de-France (region) |
Rivière, Anne-Charlotte (Goodwin Procter 202104– Partner at Paris Office before Dechert Paris + Fired Frank) | Attorney / Lawyer | Goodwin Procter (Goowin Law) (Group) | Île-de-France (region) |
Trombe, Emmanuelle (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Île-de-France (region) |
Wahr, Christine M. (McDermott Will & Emery 201709 Associate in Boston) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Massachusetts (federal state) |
Barner, Andreas (Boehringer) | Board member | Boehringer Ingelheim (Group) | Rheinland-Pfalz (federal state) |
Bencteux, Philippe (Robocath 2009– Chairman + Founder) | Board member | Robocath SAS | Normandie (Normandy) (region) |
Bizzari, Jean-Pierre (Nordic Nanovector 201605– Board Memeber before Celgene + Sanofi-Aventis) | Board member | Nordic Nanovector (Group) | Østlandet (Eastern Norway) (region) |
Dong, Jianhua (Hybiome (CN) 2009– Founder + Chairman) | Board member | Mérieux (Group) | Jiangsu (Kiangsu) (province) |
Douat, Christophe (MedinCell 201810 Board Chairman) | Board member | MedinCell (Group) | Occitanie (Occitania) (region) |
Eletr, Sam (Third Wave Technologies 200504 Director) | Board member | Hologic (Group) | United States (USA)_o |
Greig, Russell G. (Greig Biotechnology Global Consulting before 30y at GSK most recently President of SR One) | Board member | Greig Biotechnology Global Consulting Inc. | |
Hoogstraate, Janet (NorthX Biologics 202307– before Valneva Sweden AB) | Board member | NorthX Biologics Matfors AB | Sweden_o |
Meyer, François (TxCell 201504 Board Chairman) | Board member | TxCell S.A. (Euronext Paris: TXCL) | Provence-Alpes-Côte d’Azur (region) |
Sainsot, Alain (Amatsigroup 201601 Chairman) | Board member | Eurofins (Group) | Occitanie (Occitania) (region) |
Tobelem, Gérard (Theradiag 201404 Chairman) | Board member | Theradiag (Group) | Île-de-France (region) |
Peltier, Sébastien (Valbiotis 201803 Board Chairman) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Valbiotis S.A. (Euronext Growth: ALVAL) | France (region/state unspecified) |
Rüdiger, Niels S. (AH Diagnostics 202304– Board Chair + CVO for Business Development before CEO) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Dutscher (DD) (Group) | Denmark_o |
Bartonícek, Ladislav (PPF Group 201502 Board Member responsible for biotechnology) | Board member, executive | PPF Group (Group) | North Holland (province, NL) |
Bonnel, David (ImaBiotech 201901 Executive Director) | Board member, executive | ImaBiotech (Group) | Hauts-de-France (Upper France) (region) |
Brown, Stephanie (Santhera 202112– President North America + Executive Board Member before Ipsen US + Novartis US) | Board member, executive | Santhera (Group) | Massachusetts (federal state) |
Regnault, Stéphane (Vygon 201409 Chairman of Board of Management) | Board member, executive | Vygon (Group) | Île-de-France (region) |
Salles, Jean-Pierre (Provence Technologies 201406– Executive Management of Provepep before Founder of Synprosis) | Board member, executive | Provence Technologies (Group) | France (region/state unspecified) |
Schlenk, Michael (Curasan 201410– Executive Board Director before Centogene + ProBioGen) | Board member, executive | Curasan AG | Germany (state/region unspecified) |
Agarwal, Shefali (Onxeo 202201 Board Chairwoman) | Board member, non-executive | Onxeo (Group) | Île-de-France (region) |
Bennani, Youssef (Domain Therapeutics 202205 Board Chairman) | Board member, non-executive | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
Boehm, Rainer (Cellectis 201706– Board Member before 29y at Novartis) | Board member, non-executive | Cellectis (Group) | Île-de-France (region) |
Brailly, Hervé (Innate Pharma 201612– Chairman of Supervisory Board before CEO + Co-Founder) | Board member, non-executive | Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA) | Provence-Alpes-Côte d’Azur (region) |
Cawthorn, Robert (Actelion –201109 existent Chairman of Board Directors TO LEAVE BOARD in 2012) | Board member, non-executive | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
Clancy, Annette (Enyo Pharma 201806 Chair of Board of Directors) | Board member, non-executive | Enyo Pharma S.A. | Auvergne-Rhône-Alpes (region) |
Clark, Ian T. (Kite Pharma 201701– Non-executive Board Director before Roche/Genentech + Novartis + Sanofi + Ivax) | Board member, non-executive | Gilead Sciences (Group) | California (federal state) |
Colowick, Alan (Matrix Capital Management 202206) | Board member, non-executive | Matrix Capital (Group) | Massachusetts (federal state) |
Dhingra, Kapil (independent consultant + board member since 2008 before Roche + Eli Lilly) | Board member, non-executive | Mariana Oncology Inc. | Massachusetts (federal state) |
Fellner, Peter (Acambis 200703 President) | Board member, non-executive | Sanofi (Group) [since May 2011] | East of England (region) |
Galbraith, Kenneth (AnorMED 200610 Chairman + Interim CEO) | Board member, non-executive | Sanofi (Group) [since May 2011] | British Columbia |
Gemayel, Georges (201511 Non-executive Board Member of Supernus + Rapotr + Dimension + Enterome + OxThera + Orphazyme) | Board member, non-executive | Enterome S.A. | Île-de-France (region) |
Goupit, Philippe (MedDay 201501– Non-executive Board Director before Sanofi VP Corporate Licenses) | Board member, non-executive | MedDay Pharmaceuticals SAS | Île-de-France (region) |
Hascoët, Gérard (CorWave 201611 Board Chairman) | Board member, non-executive | CorWave S.A. | Île-de-France (region) |
Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007) | Board member, non-executive | Celyad (Group) | Belgium_o |
Jones, Frank (Schlumberger 200305 + InforSense Board Director 200305–) | Board member, non-executive | Schlumberger (Group) | Île-de-France (region) |
Kay, Andrew (NuCana 202012– Board Chairman also at Boards of NeRRe Tx + Blueberry Tx former CEO of Algeta) | Board member, non-executive | NuCana plc (Nasdaq: NCNA) | Scotland |
Lefèvre, Jean-Marie (MaaT Pharma 2018–202306 Board Chairman) | Board member, non-executive | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | Auvergne-Rhône-Alpes (region) |
Loria, Emile (OSE Pharma 201602 Chairman + main shareholder) | Board member, non-executive | OSE Immunotherapeutics (Group) | Île-de-France (region) |
Machielse, Ben (Mosanna Therapeutics 202207 Board Chair before Vtesse + Omthera Pharmaceuticals) | Board member, non-executive | Mosanna Therapeutics AG | Northwestern Switzerland (region) |
McKillop, Tom (former CEO of AstraZeneca) | Board member, non-executive | AstraZeneca (Group) | East of England (region) |
Meier, Thomas (Viopas Venture Consulting 202201 Managing Partner before Santhera Pharmaceuticals) | Board member, non-executive | Viopas Venture Consulting (VVC) (Group) | Northwestern Switzerland (region) |
Michel, André (Aureus Pharma 200612– Board Chairman before founder + CEO) | Board member, non-executive | Reed Elsevier (Group) | Île-de-France (region) |
Mouney, Jean-François (Genfit 201909– Board Chairman before 1999–201909 CEO + Co-Founder) | Board member, non-executive | Genfit (Group) | Hauts-de-France (Upper France) (region) |
Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH) | Board member, non-executive | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
Oesterle, Stephen (Steve) (Sigilon Therapeutics 201706 Non-exe Board Director formerly SVP Medicine + Techn Medtronic) | Board member, non-executive | Eli Lilly (Group) | Massachusetts (federal state) |
O’Neill, Julie (Hookipa 201811– non-exec Board Member as well as at DBV Technologies before Alexion + Gilead) | Board member, non-executive | Hookipa (Group) | New York (federal state) |
Papadopoulos, Stelios (Cowen –200612 retired) | Board member, non-executive | Société Générale (Group) | |
Pasternak, Richard (Abionyx 201909– Board Chairman before CEO of predecessor Cerenis) | Board member, non-executive | Abionyx (Group) | Occitanie (Occitania) (region) |
Policard, Christian (Biotech Developpement Conseils 2002 Founder + Cellectis 201106 Board Director) | Board member, non-executive | Biotech Développement Conseils (BDC) | Île-de-France (region) |
Prieels, Jean-Paul (Themis Bioscience 201505– Board Member former SVP RnD at GSK Biologicals) | Board member, non-executive | Merck (US) (MSD) (Group) | Wien (state) |
Ryckebusch, Sylvie (Domain Therapeutics 202205 Non-executive Board Member) | Board member, non-executive | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
Said, Maya (Transgene 201706– Non-Executive Board Member before Novartis + Sanofi + Boston Consulting) | Board member, non-executive | Mérieux (Group) | Grand Est (Great East) (region) |
Saporta, Albert (Biofiteam 201703– co-owner + independent Director of Hybrigenics) | Board member, non-executive | Biofiteam (Group) | Île-de-France (region) |
Schatz, Peer M. (Resolve BioSciences 202012 Chairman + Co-Founder before Qiagen 1993–201910 CEO RESIGNED 10/19) | Board member, non-executive | PS Capital Management GmbH (Peer Schatz) | Nordrhein-Westfalen (federal state) |
Smith, Kevin (Micropep Technologies 202107 Board Chairman) | Board member, non-executive | Micropep Technologies SAS | Occitanie (Occitania) (region) |
Tambuyzer, Erik (Augustine Therapeutics 202103– Board Director representing PMV formerly Genzyme Europe + Innogenetics) | Board member, non-executive | Augustine Therapeutics (BE) | Flanders (Flemish region) |
Therin, Michel (Affluent Medical 202401 Board Chair) | Board member, non-executive | Affluent Medical (Group) | Provence-Alpes-Côte d’Azur (region) |
Treillou, Jean-Luc (LNC Therapeutics 201807– Chairman before CEO) | Board member, non-executive | LNC Therapeutics (FR) | Nouvelle-Acquitaine (New Acquitaine) (region) |
Verrelst, Herman (Biocartis 202304– Board Chair before CEO before Agilent + Cartagenia + Medicim + Data4s) | Board member, non-executive | Biocartis (Group) | Flanders (Flemish region) |
Wakefield, James (Novacyt 201704 Board Chairman) | Board member, non-executive | Novacyt (Group) | Île-de-France (region) |
Weinberg, Serge (Sanofi 201906 Board Chairman) | Board member, non-executive | Sanofi (Group) [since May 2011] | Île-de-France (region) |
Werner, Thomas (Board Member of several companies before GSK SVP) | Board member, non-executive | GSK (Group) | Greater London (region) |
Andréucci, Philippe (APIX 201302 VP Business Development + Co-founder) | Business Development Manager / Strategy Manager | Analytical Pixels Technology SAS (APIX) | Auvergne-Rhône-Alpes (region) |
Arnot, Christopher (Merck (DE) 202209 Director BusDev + Licensing Gene Editing + Novel Modalities at Sigma-Aldrich) | Business Development Manager / Strategy Manager | Merck (DE) (Group) | Missouri (federal state) |
Barbaroux, Jean-Baptiste (Global Bioenergies 201710 Heead of Corporate Development) | Business Development Manager / Strategy Manager | Global Bioenergies (Group) | Île-de-France (region) |
Bauler, James (Flag Therapeutics 201901 Director Corporate Development) | Business Development Manager / Strategy Manager | Flag Therapeutics (US) | North Carolina (federal state) |
Beerman, Noah D. (Poxel 201505– EVP BusDev + President US before Coronado Biosciences + RXi Pharmaceuticals + Indevus) | Business Development Manager / Strategy Manager | Galena BioPharma Inc. | Massachusetts (federal state) |
Berthet, Pascale (TreeFrog 202002– Chief Business Development Officer before Fujifilm Cellular Dynamics + Artelis) | Business Development Manager / Strategy Manager | TreeFrog Therapeutics (Group) | Nouvelle-Acquitaine (New Acquitaine) (region) |
Bihain, Pascale (Genclis 201907 Business Development Director) | Business Development Manager / Strategy Manager | Genclis SAS | Grand Est (Great East) (region) |
Bossert, Michael (Enamine Ltd 201201 Business Development Director) | Business Development Manager / Strategy Manager | Enamine Ltd. (UA) | Ukraine_o |
Bouvier, Maud (TxCell 201601– VP Business Development before Erytech Pharma since 2005) | Business Development Manager / Strategy Manager | TxCell S.A. (Euronext Paris: TXCL) | Provence-Alpes-Côte d’Azur (region) |
Bowdish, Kathy (Sanofi 201603 Head of Sunrise Initiative) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
Boyé, Mona (Ksilink 201709 Scouting + Business Development before Alsace Biovalley 201211 Business Officer) | Business Development Manager / Strategy Manager | Ksilink (FR) | Grand Est (Great East) (region) |
Buhl, Thomas (Global Bioenergies 201606 Head of Business Development) | Business Development Manager / Strategy Manager | Global Bioenergies (Group) | Île-de-France (region) |
Carouge, Dominique (Sanofi 201802– EVP Head of Business Transformation joined Sanofi 2009 before Ernst & Young) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top